Speaker | Nadia Ashrafi, Ph.D.
Affiliation | Metabolomics Research Group | Corewell Health Research Institute | Corewell Health East William Beaumont University Hospital | Research Scientist

Metabolomic profiling of Cohort Consortium identifies prodromal biomarkers for Parkinson's disease

Part of the
Corewell Health Metabolomics Symposium

Comprehensive metabolomic profiling of the LRRK2 Cohort Consortium (LCC) identifies prodromal biomarkers for Parkinson’s Disease

Related articles

• Predictive medicine – Transform medicine with metabolomics – part 2 of 5
• N-acetyl-aspartic acid (NAA) – Significant metabolite for brain function, metabolism, and disease
• Preventive medicine – Transform medicine with metabolomics – part 1 of 5
• Citric acid – Key metabolite in energy production, bone health, and disease therapy
• Precision nutrition – Unlocking health through metabolomics